Novartis AG
Year | Mar | Jun | Sep | Dec | Annual | |
---|---|---|---|---|---|---|
2023 | 1.08 | 1.11 | 0.85 | - | - | |
2022 | 0.99 | 0.77 | 0.72 | 0.69 | - | |
2021 | 0.91 | 1.28 | 1.22 | 7.22 | 10.63 | |
2020 | 0.95 | 0.81 | 0.84 | 0.92 | 3.52 | |
2019 | 0.76 | 2.91 | 0.89 | 0.5 | 5.06 | |
2018 | 0.86 | 3.31 | 0.69 | 0.52 | 5.38 | |
2017 | 1.13 | 1.21 | 1.29 | 1.20 | 4.83 | |
2016 | 1.17 | 1.22 | 1.23 | 1.12 | 4.74 | |
2015 | 1.33 | 1.26 | 1.27 | 1.11 | 4.97 | |
2014 | 1.19 | 1.03 | 1.31 | 0.60 | 4.13 | |
2013 | 0.97 | 1.01 | 0.90 | 0.82 | 3.7 | |
2012 | 0.92 | 1.09 | 0.98 | 0.80 | 3.79 | |
2011 | 1.20 | 1.11 | 1.01 | 0.38 | 3.7 | |
2010 | 1.28 | 1.05 | 0.99 | 0.94 | 4.26 | |
2009 | 0.86 | 0.89 | 0.92 | 1.02 | 3.69 | |
2008 | 1.02 | 0.98 | 0.92 | 0.67 | 3.59 | |
2007 | 0.92 | 0.85 | 2.96 | 0.40 | 5.13 | |
2006 | 0.83 | 0.72 | 0.79 | 0.70 | 3.04 | |
2005 | 0.63 | 0.70 | 0.71 | 0.58 | 2.62 |